News about "PathogenDx receives NIH grant to develop more accu"

PathogenDx receives NIH grant to develop more accurate and f efficient COVID-19 diagnostic testing technology

PathogenDx receives NIH grant to develop more accurate and f efficient COVID-19 diagnostic testing technology

PathogenDx Inc, an Arizona-based technology company which has developed an ultra-accurate DNA-based customized pathogen testing platform for the food, agricultural and health sectors, announced that it has received a second grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH)

PathogenDx Receives NIH Grant To Develop More Accu | 19/08/2020 | By Darshana 547


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members